Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Female

Explore clinical trials studying Genital Neoplasms, Female. Study availability and eligibility vary by location and protocol.

4,668 public trials 1,054 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Female trial results

Recruiting

A Study of Raludotatug Deruxtecan With or Without Bevacizumab as First-Line Maintenance Treatment in Non-HRD-Positive Advanced Ovarian Cancer (MK-5909-006, (ENGOT-ov102/GOG-3141/ REJOICE-Ovarian 04)

NCT07776691

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +17 more
Locations
  • MedStar Washington Hospital Center ( Site 0026) Washington D.C., District of Columbia, United States
  • Texas Oncology - DFW ( Site 8005) Fort Worth, Texas, United States
  • Sourasky Medical Center ( Site 1403) Tel Aviv, Israel
View Trial Details
Recruiting

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

NCT07114601

Conditions
Breast Diseases, Breast Neoplasms, Colonic Diseases, +37 more
Locations
  • City of Hope Duarte, California, United States
  • University of California, Los Angeles (UCLA) Santa Monica, California, United States
  • Stanford University Medical Center Stanford, California, United States
  • Biogenix Molecular, LLC Miami, Florida, United States
View all 33 locations
View Trial Details
Recruiting

A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer

NCT07059845

Conditions
Adnexal Diseases, Endocrine Gland Neoplasms, Endocrine System Diseases, +13 more
Locations
  • UC San Diego Health - Moores Cancer Center /ID# 277574 La Jolla, California, United States
  • Sansum Clinic - Solvang /ID# 277712 Solvang, California, United States
  • University of Florida College of Medicine /ID# 278348 Gainesville, Florida, United States
  • Orlando Health Cancer Institute Gynecologic Cancer Center - Orlando /ID# 278623 Orlando, Florida, United States
View all 84 locations
View Trial Details
Recruiting

EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors

NCT07262619

Conditions
Advanced Solid Tumors, Endometrial Cancer, Endometrial Neoplasms, +21 more
Locations
  • Morristown Medical Center Morristown, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center (MSKCC) New York, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • GenesisCare North Shore (Oncology) Saint Leonards, New South Wales, Australia
View all 35 locations
View Trial Details
Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

NCT05112601

Conditions
Adenocarcinoma, Adnexal Diseases, Carcinoma, +28 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • University Cancer and Blood Center LLC Athens, Georgia, United States
  • Augusta University Medical Center Augusta, Georgia, United States
  • Saint Alphonsus Cancer Care Center-Boise Boise, Idaho, United States
View all 138 locations
View Trial Details

Related conditions